Background & Summary
====================

Scientists have long enlisted venoms in their quest to characterize novel molecules with biotechnological applications^[@b1],[@b2]^. The literature provides innumerous examples of venom-derived applications, ranging from biopesticides to medical applications. In particular, works on serpent venom are, unarguably, success stories. Some examples are: Batroxobin, a widely used thrombin-like enzyme and commonly extracted from the venom of *Bothrops atrox* and *Bothrops moojeni*, has been used as a replacement for thrombin in bleeding injuries^[@b3]^; Ecarin, from *Echis carinatus*, as the primary reagent for laboratorial tests that monitor anticoagulation^[@b4]^; and Captopril, developed from peptides of the *Bothrops jararaca* venom, as a widely adopted inhibitor of the angiotensin converting enzyme (ACE). Other examples of venom-derived drugs include: Aggrastat, for myocardial infarct and ischemia; Ancrod, for stroke; Defibrase, for acute cerebral infarction and angina pectoris; Exanta, used as an anti-coagulant; Hemocoagulase, for hemorrhage; and Integrilin, for acute coronary syndrome^[@b5]^. Venoms have also been used to search for inhibitors derived from other species (e.g., *Didelphis marsupialis*)^[@b6],[@b7]^.

Motivated by all the successful research on snake venoms, efforts have been geared towards spider toxins. In particular, those from the *Loxosceles* genus are already being used in at least four general application fronts, viz.: as therapeutic anti-venom sera^[@b8]^; as tools in molecular and cellular biology research; and as aids in drug development and production of selective and environmentally friendly bioinsecticides^[@b5]^. Peptides originating from the venom of *Thrixopelma pruriens* have been used in the treatment of pain and inflammation^[@b9]^; the T×2--5 and T×2--6 neuropeptides from the *Phoneutria nigriventer* venom, for treating erectile dysfunctions^[@b10]^; and distinct bioactive peptides from spider venoms, in the treatment of diverse diseases, such as cancer^[@b11]^. Taken together, toxins have served as an endless treasure trove for biotechnological applications.

Spider venoms, in particular, comprising mainly proteins and peptides^[@b2],[@b5],[@b12],[@b13]^ and displaying great diversity in their toxins, have drawn considerable attention. Yet, characterizing venoms poses great challenges even for state-of-the-art proteomic strategies: in fact, most species lack a reference sequence genome^[@b14]^ and the post-translational modifications of venoms vary greatly. Moreover, current mainstream strategies are not tailored towards performing *de novo* sequencing of the large (i.e., greater than tryptic), biologically active peptides that abound in venoms. Indeed, peptide-centric approaches are oblivious to whether a sequenced peptide originates from a larger peptide or a full protein, but obtaining the complete sequence of these larger molecules will undoubtedly fuel a great diversity of biotechnological applications. In this regard, it is our view that widely adopted proteomic strategies such as peptide spectrum matching (PSM)^[@b15],[@b16]^ and mainstream *de novo* sequencing^[@b17]^ only reveal the tip of the iceberg in terms of what can be unveiled from venoms.

One of our goals has been to characterize the venom of the so-called brown spiders (the *Loxosceles* genus). Altogether, their venom is composed of a complex cocktail of biologically active compounds, with toxins ranging up to 40 kDa and over^[@b18]^. To the best of our knowledge, an in-depth, comprehensive proteomic profiling of the *Loxosceles* venom tailored towards the discovery of new molecules has so far remained elusive. Currently, there are several descriptions of enzymatic and non-enzymatic proteins from distinct *Loxosceles* species^[@b19],[@b20]^. In 2003, a study aimed to investigate whether venoms of phylogenetically-related groups of *Haplogyne* spiders possess sphingomyelinase-D (SMD) toxins^[@b21]^. The study included 10 *Loxosceles* species and 2 *Sicarius* species, among other spider genera. The Amplex Red Phospholipase-D assay kit indicated SMD activity and these results were further supported by a Surface-Enhanced Laser Desorption/Ionization (SELDI) Time-of-Flight (TOF) analysis showing mass spectral peaks with m/z's corresponding to those of SMD. *Loxosceles* SMDs, later referred to as phospholipases-D (PLDs), are known to be the major component of *Loxosceles* venoms and are the most well characterized toxin family in brown spider venoms. In 2005, two-dimensional protein profiles of the *L. intermedia*, *L. laeta*, and *L. gaucho* venoms were determined, but protein identification was focused only on the SMD toxins of the *L. gaucho* venom^[@b22]^. The identification of seven spots of interest was first attempted using data from Matrix-Assisted Laser Desorption/Ionization (MALDI) Time-of-Flight (TOF) Mass Spectrometry (MS) and Electrospray Ionization (ESI) quadrupole-time-of-flight Tandem Mass Spectrometry (MS/MS) for direct search of raw data using MASCOT^[@b22]^. Since the searches retrieved no significant match, *de novo* sequencing was performed and the resulting sequences were BLASTed against the non-redundant sequences, allowing SMD identification for all analyzed spots^[@b22]^. Only in 2009 was a proteomic study described that targeted the total protein content of the *Loxosceles* venom^[@b23]^. Although the *L. intermedia* venom was analyzed using Multi-Dimensional Protein Identification Technology (MudPIT)^[@b24]^, only 39 proteins were identified. Of these proteins, only 14 were described as toxins generally found in animal venoms^[@b23]^. Thus, this proteomic study seems to have severely underestimated the great toxin diversity of the *Loxosceles* venom, particularly in comparison to the many publications that already described distinct molecular clones from venoms of different *Loxosceles* species^[@b25]^. Transcriptome analyses of the *L. laeta* and *L. intermedia* venoms revealed a huge complexity of brown-spider venoms^[@b19],[@b20]^. Specifically, the analysis of the *L. intermedia* venom described three classes of toxins comprising most toxin-encoding transcripts, such as peptides of low molecular mass (55.9%), astacin-like proteases (22.6%), and PLDs (20.2%). Also, transcripts similar to hyaluronidases, serine proteases, serine protease inhibitors, venom allergens, and members of the translationally controlled tumor protein (TCTP) family presented low levels of expression^[@b20]^. Although considerable information is now available on venom gland transcripts of *L. intermedia*, the total protein content of this venom has remained unclear. A previous study from our group applied two-dimensional immunoblots and zymograms on the venom of *L. intermedia*, *L. laeta*, and *L. gaucho*, and revealed several spots with differential volume containing proteins having gelatinolytic activity corresponding to astacin-like proteases^[@b33]^. These results corroborate that venoms from these species present a broad astacin-like family with many isoforms^[@b22],[@b33],[@b34]^.

The lack of genomic data from this arachnid prevents employing the PSM approach in full, so most of the weightlifting must be accomplished through *de novo* sequencing. Mainstream *de novo* sequencing, however, cannot efficiently handle unanticipated post-translational modifications, being far more prone to generating sequencing errors. This is because various molecules fail to provide enough mass spectral peaks during fragmentation to enable the sequencing of full peptides. To overcome these limitations, our dataset was acquired with multiple dissociation strategies applied to the same precursor (e.g., collision-induced dissociation (CID), higher-energy collisional dissociation (HCD), and electron-transfer dissociation (ETD)), thereby enabling the use of state-of-the-art *de novo* sequencing algorithms. These capitalize on complementary dissociation information and thus achieve unprecedented sequencing accuracy^[@b35],[@b36]^. The use of different proteolytic enzymes on the venom aliquots unlocks the application of another very powerful paradigm, that of spectral networks^[@b37],[@b38]^. These 'specnets' align spectra against one another, ultimately allowing the detection of unanticipated post-translational modifications. Moreover, they can assemble consensus mass spectra from overlapping peptides yielded by different proteolytic digests. A consensus spectrum thus obtained presents a better signal-to-noise ratio and allows for the *de novo* sequencing of amino-acid stretches far longer than those handled by the conventional approach. Once high-confidence *de novo* data are available, it becomes possible to employ tools, such as PepExplorer^[@b39]^ or Meta-SPS^[@b37]^, that apply pattern recognition approaches to the mapping of *de novo* sequencing data against sequences from homologous organisms, thereby facilitating biological interpretation.

By themselves, the meta-contig assemblies provided by spectral networks are not enough for one to conclude whether a biomolecule obtained 100% coverage. To pave the way in this direction, top-down proteomic data in combination with MS3 (i.e., product ion(s) selected from an MS/MS spectrum further fragmented and producing another tandem mass spectrum) and ETD were also acquired for a partition of the venom molecules into two sets (\<\~10 kDa and \>\~10 kDa). The top-down strategy consists of injecting intact proteins into the mass spectrometer, thus doing away with the inference limitations of the peptide-centric approach^[@b40]^. This provides complementary information to that of the networks and helps in the discovery of how much is required for obtaining full coverage. We anticipate that these data will be fundamental in the development of next-generation algorithms capable of bridging the gap between bottom-up, middle-down, and top-down proteomics.

Here, we present the first multi-protease, multi-dissociation, bottom-up-to-top-down proteomic dataset of the venom of *L. intermedia,* the 'urban' spider species commonly found in the city of Curitiba, Brazil^[@b41]^, along with an analysis using state-of-the-art tools. The approach stems from the motivation that multiple enzyme digestion increases protein coverage^[@b42]^, besides relying on different activation and acquisition methods.

Methods
=======

Sample preparation
------------------

Adult *L. intermedia* specimens (both male and female) were collected in the wild in accordance with the Brazilian Federal System for Authorization and Information on Biodiversity (SISBIO-ICMBIO, license number 29801-1). Venom from 200 spiders was extracted through the electrostimulation method^[@b43]^ and immediately diluted in ammonium bicarbonate buffer 0.4 M/urea 8 M. Protein concentration was determined through the Coomassie blue method, using bovine serum albumin (BSA) as standard curve^[@b44]^. First, the venom was separated into two fractions using an ultra-filter unit (MW cutoff 10 kDa) (Millipore), one fraction containing venom proteins above \~10 kDa (400 μg) and the other containing venom proteins and peptides bellow \~10 kDa (90 μg). All procedures described next were performed equally for each fraction, after further dividing it into four aliquots, each of which was reduced with dithiothreitol (DTT) to a final concentration of 25 mM for 3 h at room temperature. Afterwards, the samples were alkylated with iodacetamide (IAA) to a final concentration of 80 mM for 15 min at room temperature in the dark. Each aliquot was digested with one of the follow enzymes: trypsin (Trypsin Gold, Mass Spectrometry Grade, Promega Corporation, Madison, cat. No. V5280, WI, USA), chymotrypsin (Promega, cat. No. V1062), and pepsin (Promega, cat. No. V1959) at the ratio of 1:50 (E:S). We note that an additional aliquot was stored and not digested. Three aliquots were incubated individually with each enzyme for 18 h, at 25 °C for chymotrypsin and 37 °C for trypsin and pepsin. The other aliquot was incubated for only 4 h with trypsin at 37 °C. Each digested fraction was divided into three aliquots and desalted with ultra-micro C-18 spin columns according to the manufacturer's instructions (Harvard Apparatus). One of these three aliquots was stored for future use, another had its peptides desalted and directly submitted to reverse phase chromatography coupled online with an Orbitrap XL mass spectrometer. The third aliquot of the desalted peptides was eluted with 70% acetonitrile (ACN) and 0.1% formic acid, then dried in a speed vacuum concentrator, suspending buffer C (i.e., 10 mM of K~2~HPO~4~, 25%ACN, pH=3.0). Afterwards, the sample was passed through a micro strong cation exchanged spin column (SCX) according to the manufacturer's instructions (Harvard Apparatus). Briefly, the column was equilibrated with buffer C, centrifuged for 1 min at 100×g, and the sample was eluted from the SCX spin column with increasing concentration of KCl, i.e., 100, 170, 290, and 400 mM. Finally, each fraction was desalted once more with ultra-micro C-18 spin columns according to the manufacturer's instructions (Harvard Apparatus). All columns were then washed ten times with 0.1% formic acid and the peptides were eluted with buffer B (i.e., 70% acetonitrile, 0.1% formic acid) to proceed to next step.

Mass spectrometry analysis
--------------------------

Each fraction of peptides, including the non-fractionated as well as those from the SCX fractionation, was previously desalted and subjected to an LC-MS/MS analysis on a nano-LC 1D plus System (Eksigent, Dublin, CA), an ultra-high performance liquid chromatography (UHPLC) system coupled with an LTQ-Orbitrap XL ETD (Thermo, San Jose, CA) mass spectrometer, at the Mass Spectrometry Facility RPT02H of the Carlos Chagas Institute (Fiocruz, Brazil). In these analyses, the peptide mixtures were loaded onto a column (75 mm i.d., 15 cm long), packed in-house with a 3.2 μm ReproSil-Pur C18-AQ resin (Dr Maisch) with a flow of 500 nl/min and subsequently eluted with a flow of 250 nl/min from 5 to 40% ACN in 0.5% formic acid in a 120 min gradient. The mass spectrometer was set to data-dependent mode to automatically switch between MS and MS/MS acquisition. Full-scan MS spectra (m/z 350--1,800) were acquired in the Orbitrap analyzer with resolution R=60,000 at m/z 400 (after accumulation to a target value of 1,000,000 in the linear trap) using survey mode. The three most intense ions were sequentially isolated and fragmented using CID, HCD, and ETD for the same precursor. Previous target ions selected for MS/MS were dynamically excluded for 60 s. The total cycle time was approximately 5 s. The general mass spectrometric conditions were: spray voltage, 2.4 kV; no sheath or auxiliary gas flow; ion transfer tube temperature, 100 °C; collision gas pressure, 1.3 mTorr; normalized collision energy using wide-band activation mode; 35% for MS/MS. Ion selection thresholds were of 5,000 counts for MS/MS. The parameters for each fragmentation type in MS/MS acquisitions were as follows. For CID: isolation width, m/z 2.5; normalized collision energy, 35; activation, q=0.25; activation time, 30 ms. For HCD: isolation width, m/z 2.5; normalized collision energy, 35; activation time, 30 ms; full width at half maximum resolution, 15,000. For ETD: isolation width, m/z 2.5; activation time, 100 ms.

Bioinformatics analysis
-----------------------

The *de novo* sequencing approach employed in this work utilized multiple MS/MS spectra from overlapping peptides, generated from multiple proteases and of precursors analyzed with CID, HCD, and ETD spectrum triples. Each was then converted into prefix residue mass (PRM) spectra. In this conversion, MS/MS peak masses were converted into putative cumulative precursor fragment masses, with intensity scores determined from likelihood models specific to each fragmentation mode. Triples of PRM spectra from the same precursor were then merged into a single PRM spectrum per precursor by adding scores for matching peak masses. Spectral-network algorithms, implemented in the ProteoSAFe web platform that is freely accessible at <http://proteomics.ucsd.edu/ProteoSAFe/>, were then used to align merged PRM spectra from peptides with overlapping sequences. Moreover, A-Bruijn algorithms were used to integrate these alignments into assembled contigs.

Each contig was then used to construct a consensus contig spectrum, or meta-contig, capitalizing on the corroborating evidence from all of its assembled spectra to yield a high-quality consensus *de novo* sequence^[@b36]^. Subsequently, the Meta-SPS algorithm was used to align the meta-contigs against a FASTA sequence database^[@b37]^. This database contained all *Loxosceles* sequences from UniProt, all from the transcriptome of the *L. intermedia* venom gland^[@b20]^, and an internal database with common mass spectrometry contaminants and proteases.

A summary of this methodology is found in [Fig. 1](#f1){ref-type="fig"}.

Data Records
============

Our bioinformatics analysis disclosed a list of 190 proteins ([Table 1](#t1){ref-type="table"}). As far as we know, this is the most complete comprehensive proteomic profiling of the *L. intermedia* venom. All mass spectrometry data are available from both the ProteomeXchange Consortium via the PRIDE^[@b45]^ partner repository, with dataset identifier PXD005523 (Data Citation 1), and our servers (<http://proteomics.fiocruz.br/pcarvalho/lintermedia/venom/>). A full list of the proteins, meta-contigs, and homologous sequences is made available in [Table 1](#t1){ref-type="table"}.

All Meta-SPS results for \>\~10 kDa and \<\~10 kDa, together with the parameter files used for running the software, are available as separate material (MetaSPS_Results.xlsx, Data Citation 2). The results are presented in six tabs, viz., for \>\~10 kDa grouped by contig, \>\~10 kDa grouped by spectrum, \>\~10 kDa parameter file, \<\~10 kDa grouped by contig, \<\~10 kDa grouped by spectrum, and \<\~10 kDa parameter file.

Technical Validation
====================

The lack of any previous comprehensive proteomic analysis of the *Loxosceles* venom demonstrates that studying this venom in detail has been a challenge, one that stems from the organism being highly non-canonical and from the fact that protein sequences for it have remained scarce in databases. The present work circumvented these obstacles by using a combination of shotgun proteomic experiments and different tools to generate and analyze large proteomic datasets and *de novo* sequencing results.

Our results revealed 190 protein identifications, including all classes of toxins described in previous transcriptome analyses^[@b19],[@b20]^ ([Table 2](#t2){ref-type="table"} (available online only)). Our approach identified both high- and low-abundance toxins of the *L. intermedia* venom, as well as homolog sequences from distinct *Loxosceles* species (astacin-like proteases, PLDs, peptides, TCTPs, hyaluronidases, allergens, serine proteases, serine protease inhibitors, and housekeeping proteins) ([Table 2](#t2){ref-type="table"} (available online only)). These data reinforce the holocrine nature of the *Loxosceles* venom gland^[@b23]^ and demonstrate that its venom is composed of toxins and housekeeping proteins originating from epithelial-cell content, such as the angiotensin converting enzyme, the 60S ribosomal protein, the Na-Pi co-transporter, and the myosin heavy chain ([Table 2](#t2){ref-type="table"} (available online only)). Our results, therefore, validate the method used for analyzing the proteome of an organism with non-sequenced genome.

Taken together, the identified toxins in the *L. intermedia* venom include representatives from all toxin groups, even if in low abundances (as in the case of, e.g., hyaluronidases and serine proteases). We also find it noteworthy that we obtained significant coverage of the three major families present in the venom, viz., PLDs, astacin-like metalloproteases, and ICK peptides. These families are of great importance for studies of the brown-spider envenomation features and of biotechnological and medical applications.

Many of the aligned contigs mapped to distinct PLD isoforms from a variety of *Loxosceles* species. In fact, these toxins are the most studied and well-characterized components of the *Loxosceles* venom^[@b5],[@b20],[@b26],[@b31],[@b46]^. PLDs are able to reproduce the deleterious effects observed in loxoscelism and represent a great target for drug discovery against brown-spider envenomation^[@b2],[@b5]^.

As for the astacin-like metalloproteases identified, we note that astacins were first described as an animal-venom component in 2007 ([@b28]) and only later recognized as a family of toxins present in the *Loxosceles* venom^[@b33]^. These toxins present proteolytic activity on distinct extracellular matrix proteins and are related to the hemostatic effects in loxoscelism^[@b43],[@b49]^.

ICK peptides, the major components of the *L. intermedia* venom-gland transcriptome (54,9% of the expressed sequence tags), were identified with correspondence to all four different ICK peptides described for *L. intermedia* (LiTx1, LiTx2, LiTx3, and LiTx4)^[@b50],[@b51]^. These ICK peptides, also called knottins, are characterized by the neurotoxic properties they exhibit on ion channels and receptors expressed in the nervous systems of insects and mammals^[@b52]^. The high expression of LiTx transcripts, which correlates with the proteomic results found herein, are consistent with the venom's effects of paralyzing and killing both preys and predators^[@b1],[@b20],[@b51]^.
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###### Identifications resulting from the \>\~10 kDa and \<\~10 kDa venom fractions

                                            **\>\~10 kDa**   **\<\~10 kDa**   **Together**
  ---------------------------------------- ---------------- ---------------- --------------
  **No. of spectral triplets**                  41,386           36,625          78,011
  **No. of contigs**                             642              454            1,096
  **No. of homologous sequences**                440              228             190
  **No. of** ***de novo*** **sequences**         642              454            1,096
  **No. of proteins**                            440              228             190
  **No. of raw files**                            42               46              88

###### Meta-contig assemblies output by Meta-SPS on shotgun data from the venom of Loxosceles intermedia and corresponding proteins mapped per similarity

                                    ***de novo*** **sequence**                                                                                                 **Protein index**                    **Protein name**                                                 **Species**
  --------------------------------- -------------------------------------------------------------------------------------------------------------------------- ------------------------------------ ---------------------------------------------------------------- --------------------------------------
  Toxin class                                                                                                                                                                                                                                                         
   Metalloprotease                  \[211.812\]\[154.295\]\[261.952\]Y\[200.869\]NMIYGAG                                                                       gi 116733934 gb ABK20019.1           astacin-like metalloprotease toxin precursor                     *Loxosceles intermedia*
                                    \[168.09\]PDATIVY\[128.106\]                                                                                               gi 257219865 gb ACV52010.1           astacin-like metalloprotease toxin 2 precursor                   *Loxosceles intermedia*
                                    DDYVI\[262.263\]\[128.148\]                                                                                                gi 257219867 gb ACV52011.1           astacin-like metalloprotease toxin 3 precursor                   *Loxosceles intermedia*
                                    GVIIHE\[291.835\]\[227.31\]GFY                                                                                             TSA 1, Contig: LIS109                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    GTCICDGGSCNC\[128.125\]R                                                                                                   TSA 1, Contig: LIS137                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    \[127.832\]VRNGCNT\[252.829\]DVGIR                                                                                         TSA 1, Contig: LIS187                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    RDAP\[215.036\]\[170.707\]\[196.097\]IG\[153.721\]F                                                                        TSA 2, Contig: LIC247                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    GNMFSCWSTVGMR                                                                                                              TSA 2, Contig: LIC331                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    INIIY\[128.088\]                                                                                                           TSA 2, Contig: LIS63                 putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    \[128.115\]PCGNNV\[274.883\]DP\[227.119\]                                                                                  TSA 3, Contig: LIC321                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    GAAGVTIINPAAGR                                                                                                             TSA 3, Contig: LIC369                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    NAVSSD\[244.341\]                                                                                                          TSA 3, Contig: LIS121                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    GVIIHEIGHVIGF                                                                                                              sp A0FKN6 VMPA LOXIN                 astacin-like metalloprotease toxin precursor                     *Loxosceles intermedia*
                                    \[153.983\]IDI\[128.103\]\[241.226\]NTIY                                                                                   tr C9D7R2 C9D7R2 LOXIN               astacin-like metalloprotease toxin 2 precursor                   *Loxosceles intermedia*
                                    GDSRIWPDGVVIY                                                                                                              tr C9D7R3 C9D7R3 LOXIN               astacin-like metalloprotease toxin 3 precursor                   *Loxosceles intermedia*
                                    F\[242.232\]D\[275.039\]\[128.008\]RCVY                                                                                    TSA 1, Contig: LIC313                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    \[127.931\]D\[128.061\]\[241.133\]DR\[184.194\]\[174.03\]PY                                                                TSA 1, Contig: LIC411                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    IEAGDV\[128.029\]GIGCGG                                                                                                    TSA 1, Contig: LIS117                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    \[349.495\]IGITGF                                                                                                          TSA 1, Contig: LIS234                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    \[184.051\]N\[257.098\]\[216.857\]I\[259.978\]E\[291.043\]SIPSN                                                            TSA 1, Contig: LIS98.                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    F\[127.959\]NHDS\[204.387\]D\[242.74\]                                                                                     TSA 2, Contig: LIC228                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    RDAP\[215.036\]\[170.707\]\[196.097\]IG\[153.721\]F                                                                        TSA 2, Contig: LIC247                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    GIGIT\[128.015\]PCTCS\[198.07\]C\[225.217\]                                                                                TSA 2, Contig: LIC331                putative astacin-like metalloprotease                            *Loxosceles intermedia*
                                    INIIY\[128.088\]                                                                                                           TSA 2, Contig: LIS63                 putative astacin-like metalloprotease                            *Loxosceles intermedia*
   Phospholipase-D                  \[198.061\]YITAST\[234.471\]D\[127.861\]\[128.324\]DFA\[128.058\]                                                          gi 141452623 gb ABO87656.1           dermonecrotic toxin isoform 6                                    *Loxosceles intermedia*
                                    HYEIF\[128.043\]GFR                                                                                                        gi 156067386 gb ABU43333.1           loxtox i5                                                        *Loxosceles intermedia*
                                    \[241.121\]ICAIVI\[202.255\]G\[245.305\]II\[326.299\]                                                                      gi 156067390 gb ABU43335.1           loxtox i7                                                        *Loxosceles intermedia*
                                    \[185.016\]CC\[215.047\]DVANAEAW                                                                                           gi 224472025 gb ACN48894.1           sphingomyelinase D-like protein, partial                         *Loxosceles arizonica*
                                    VATYDDN\[283.158\]V\[248.057\]\[128.175\]\[128.114\]                                                                       gi 224472109 gb ACN48936.1           sphingomyelinase D-like protein, partial                         *Loxosceles spadicea*
                                    I\[128.164\]\[185.033\]\[320.151\]\[199.846\]V\[128.057\]V\[257.079\]                                                      gi 224472111 gb ACN48937.1           sphingomyelinase D-like protein, partial                         *Loxosceles variegata*
                                    \[258.156\]GS\[215.905\]C\[128.131\]TN\[142.105\]                                                                          gi 224472117 gb ACN48940.1           sphingomyelinase D-like protein, partial                         *Loxosceles arizonica*
                                    \[323.223\]SIDIIAS\[128.107\]                                                                                              gi 224472133 gb ACN48948.1           sphingomyelinase D-like protein, partial                         *Loxosceles hirsuta*
                                    WVI\[211.923\]\[323.19\]\[193.88\]G\[184.835\]DWG\[288.885\]AGVVGGIV\[168.053\]                                            gi 224472141 gb ACN48952.1           sphingomyelinase D-like protein, partial                         *Loxosceles rufescens*
                                    IA\[277.273\]D\[217.017\]F\[286.991\]V\[275.199\]                                                                          gi 224472143 gb ACN48953.1           sphingomyelinase D-like protein, partial                         *Loxosceles arizonica*
                                    \[127.947\]IAEWFDVDVC                                                                                                      gi 224472147 gb ACN48955.1           sphingomyelinase D-like protein, partial                         *Loxosceles laeta*
                                    I\[172.141\]NFMN\[128.005\]R                                                                                               gi 224472157 gb ACN48960.1           sphingomyelinase D-like protein, partial                         *Loxosceles laeta*
                                    AGADGM\[212.996\]DFP\[127.998\]                                                                                            gi 224472195 gb ACN48979.1           sphingomyelinase D-like protein, partial                         *Loxosceles aff. Spinulosa GJB-2008*
                                    \[128.05\]\[346.235\]FGWEIC\[128.103\]                                                                                     gi 224472201 gb ACN48982.1           sphingomyelinase D-like protein, partial                         *Loxosceles aff. Spinulosa GJB-2008*
                                    I\[128.005\]NYWNNGDNG\[230.782\]                                                                                           gi 225008387 gb ACN48920.2           sphingomyelinase D-like protein, partial                         *Loxosceles sabina*
                                    \[234.124\]IIISI\[211.97\]T\[220.159\]Y\[128.131\]                                                                         gi 225008389 gb ACN48924.2           sphingomyelinase D-like protein, partial                         *Loxosceles variegata*
                                    \[217.067\]VDDGS\[127.933\]\[261.153\]IGGDSCC\[127.973\]                                                                   gi 225008391 gb ACN48959.2           sphingomyelinase D-like protein, partial                         *Loxosceles laeta*
                                    \[202.038\]TYEDN\[283.238\]VTF\[128.109\]A                                                                                 gi 49458048 gb AAT66074.1            sphingomyelinase D-like protein 3, partial                       *Loxosceles boneti*
                                    WENF\[229.222\]FI\[128.141\]                                                                                               gi 49458050 gb AAT66075.1            sphingomyelinase D protein 1, partial                            *Loxosceles reclusa*
                                    IATYDDN\[283.149\]\[128.13\]\[128.098\]                                                                                    gi 49458052 gb AAT66076.1            sphingomyelinase D protein 2, partial                            *Loxosceles reclusa*
                                    WSR\[225.203\]IWDIAHM                                                                                                      gi 81343346 gb ABB71184.1            dermonecrotic toxin isoform 3                                    *Loxosceles intermedia*
                                    \[128.059\]SSI\[185.218\]DN\[127.961\]AY\[128.189\]AGVNMATDI\[275.181\]                                                    gi 90192366 gb ABD91846.1            dermonecrotic toxin isoform 4                                    *Loxosceles intermedia*
                                    \[259.057\]SFADYIDYMR                                                                                                      gi 90192368 gb ABD91847.1            dermonecrotic toxin isoform 5                                    *Loxosceles intermedia*
                                    AIC\[262.118\]N\[213.308\]\[157.942\]IF\[269.463\]M                                                                        TSA 1, Contig: LIC336                putative phospholipase-D                                         *Loxosceles intermedia*
                                    \[128.065\]PI\[257.302\]\[168.016\]\[128.103\]                                                                             TSA 1, Contig: LIS80                 putative phospholipase-D                                         *Loxosceles intermedia*
                                    WVI\[213.173\]FE\[230.5\]VEDWG\[289.028\]AGN\[198.021\]IV\[168.053\]                                                       TSA 3, Contig: LIC182                putative phospholipase-D                                         *Loxosceles intermedia*
                                    CENISTDD\[214.057\]R                                                                                                       TSA 3, Contig: LIC203                putative phospholipase-D                                         *Loxosceles intermedia*
                                    R\[169.813\]\[231.411\]ANPIGR                                                                                              TSA 3, Contig: LIC334                putative phospholipase-D                                         *Loxosceles intermedia*
                                    \[127.988\]AE\[300.164\]D\[128.052\]IF\[128.126\]I\[255.151\]                                                              TSA 3, Contig: LIC352                putative phospholipase-D                                         *Loxosceles intermedia*
                                    WVIGG\[184.011\]A\[216.684\]\[200.309\]T\[200.21\]\[184.253\]\[200.309\]\[216.684\]GVVGGIV\[168.237\]                      TSA 3, Contig: LIC395                putative phospholipase-D                                         *Loxosceles intermedia*
                                    \[255.268\]TCEYIEI\[245.969\]DSNYSEIG\[224.144\]                                                                           TSA 3, Contig: LIC419                putative phospholipase-D                                         *Loxosceles intermedia*
                                    GEEYVNVFPMGIR                                                                                                              TSA 3, Contig: LIC423                putative phospholipase-D                                         *Loxosceles intermedia*
                                    \[256.067\]\[269.811\]\[259.263\]\[227.115\]GHEPHC\[299.732\]                                                              TSA 3, Contig: LIS9                  putative phospholipase-D                                         *Loxosceles intermedia*
                                    \[128.078\]\[128.124\]AGV\[128.053\]D\[128.036\]EHIW                                                                       sp A4USB4 A51 LOXIN                  phospholipase D LiSicTox-alphaV1 Dermonecrotic toxin 6           *Loxosceles intermedia*
  Toxin class                                                                                                                                                                                                                                                         
   Phospholipase-D                  \[278.133\]A\[127.914\]ARDAG\[128.044\]V\[127.924\]                                                                        sp B2KKW0 A22 LOXIN                  phospholipase D LiSicTox-alphaII2 Loxtox i5                      *Loxosceles intermedia*
                                    TARDVA                                                                                                                     sp C0JAQ5 A1IA1 LOXHI                phospholipase D LhSicTox-alphaIA2ai Dermonecrotic toxin          *Loxosceles hirsuta*
                                    \[144.086\]\[196.168\]\[128.016\]\[299.803\]\[217.693\]DNGNN\[142.216\]\[128.015\]                                         sp C0JAR3 A1IA6 LOXHI                phospholipase D LhSicTox-alphaIA2avi Dermonecrotic toxin         *Loxosceles hirsuta*
                                    PI\[128.15\]TD\[276.095\]\[260.159\]\[226.968\]                                                                            sp C0JAR7 A1IA7 LOXHI                phospholipase D LhSicTox-alphaIA2avii Dermonecrotic toxin        *Loxosceles hirsuta*
                                    \[128.069\]\[314.204\]\[266.04\]EIIE\[128.136\]VGY                                                                         sp C0JAS6 A1I1 LOXSP                 phospholipase D LspaSicTox-alphaIA2i Dermonecrotic toxin         *Loxosceles spadicea*
                                    \[128.135\]G\[238.403\]YEDNPW                                                                                              sp C0JAT4 A1H1 LOXHI                 phospholipase D LhSicTox-alphaIA1i Dermonecrotic toxin           *Loxosceles hirsuta*
                                    \[285.246\]TIT\[127.957\]\[128.38\]\[193.725\]PE\[244.902\]\[128.249\]F\[300.312\]                                         sp C0JAU6 A1LC LOXAR                 phospholipase D LarSicTox-alphaIB2c Dermonecrotic toxin          *Loxosceles arizonica*
                                    IISI\[211.095\]ID\[300.088\]                                                                                               sp C0JAV3 A1KA1 LOXAP                phospholipase D LapSicTox-alphaIB1ai Dermonecrotic toxin         *Loxosceles apachea*
                                    \[128.046\]T\[261.162\]\[127.9\]SAG                                                                                        sp C0JAX3 A1MA1 LOXDE                phospholipase D LdSicTox-alphaIB3ai Dermonecrotic toxin          *Loxosceles deserta*
                                    YWTVD\[128.227\]Y                                                                                                          sp C0JAY0 A1MA6 LOXDE                phospholipase D LdSicTox-alphaIB3ai Dermonecrotic toxin          *Loxosceles deserta*
                                    GIIISI\[250.013\]IAHY                                                                                                      sp C0JAZ1 A1OA1 LOXVA                phospholipase D LvSicTox-alphaIC1ai Dermonecrotic toxin          *Loxosceles variegata*
                                    NAIETDVT                                                                                                                   sp C0JAZ4 A1OB1 LOXVA                phospholipase D LvSicTox-alphaIC1bi Dermonecrotic toxin          *Loxosceles variegata*
                                    \[127.882\]GI\[185.036\]EGC\[200.002\]\[372.207\]ICA                                                                       sp C0JAZ8 A1OB5 LOXVA                phospholipase D LvSicTox-alphaIC1bv Dermonecrotic toxin          *Loxosceles variegata*
                                    R\[227.227\]TT\[154.041\]V                                                                                                 sp C0JB02 A1OD LOXRU                 phospholipase D LruSicTox-alphaIC1d Dermonecrotic toxin          *Loxosceles rufescens*
                                    GEND\[170.749\]N\[270.185\]AY                                                                                              sp C0JB04 A1P LOXRU                  phospholipase D LruSicTox-alphaIC2 Dermonecrotic toxin           *Loxosceles rufescens*
                                    \[128.095\]EVIGVTII\[143.89\]TCEAH\[252.229\]\[210.281\]D\[274.244\]                                                       sp C0JB05 A21 LOXSP                  phospholipase D LspaSicTox-alphaII1 Dermonecrotic toxin          *Loxosceles spadicea*
                                    FCGC\[128.12\]AWNPGHC\[261.261\]\[127.94\]                                                                                 sp C0JB06 A21 LOXVA                  phospholipase D LvSicTox-alphaII1 Dermonecrotic toxin            *Loxosceles variegata*
                                    Y\[293.065\]PCDCF                                                                                                          sp C0JB07 A21 LOXAP                  phospholipase D LapSicTox-alphaII1 Dermonecrotic toxin           *Loxosceles apachea*
                                    R\[312.174\]\[247.035\]\[256.156\]AVN                                                                                      sp C0JB09 A31 LOXAR                  phospholipase D LarSicTox-alphaIII1 Dermonecrotic toxin          *Loxosceles arizonica*
                                    \[349.464\]NDGCP\[314.14\]CNDW                                                                                             sp C0JB12 A332 LOXLA                 phospholipase D LlSicTox-alphaIII3ii Dermonecrotic toxin         *Loxosceles laeta*
                                    N\[128.122\]AGV\[128.154\]DREHVW                                                                                           sp C0JB14 A411 LOXHI                 phospholipase D LhSicTox-alphaIV1i Dermonecrotic toxin           *Loxosceles hirsuta*
                                    VGGSCNDD\[127.823\]VCC\[128.169\]GG\[128.002\]                                                                             sp C0JB18 A411 LOXAM                 phospholipase D LamSicTox-alphaIV1i Dermonecrotic toxin          *Loxosceles amazonica*
                                    RIANYDD\[345.981\]\[289.109\]F                                                                                             sp C0JB22 A41 LOXAR                  phospholipase D LarSicTox-alphaIV1 Dermonecrotic toxin           *Loxosceles arizonica*
                                    WFDVDVC\[128.184\]GG                                                                                                       sp C0JB23 A411 LOXLA                 phospholipase D LlSicTox-alphaIV1i Dermonecrotic toxin           *Loxosceles laeta*
                                    \[256.225\]F\[315.247\]N\[251.495\]W\[128.071\]\[171.981\]GI\[214.973\]                                                    sp C0JB25 A421 LOXLA                 phospholipase D LlSicTox-alphaIV2i Dermonecrotic toxin           *Loxosceles laeta*
                                    \[201.075\]DDD\[183.982\]D\[342.088\]\[248.103\]\[282.879\]W\[260.214\]                                                    sp C0JB29 A43 LOXLA                  phospholipase D LlSicTox-alphaIV3 Dermonecrotic toxin            *Loxosceles laeta*
                                    FI\[128.05\]GDYINV                                                                                                         sp C0JB30 A71 LOXAR                  phospholipase D LarSicTox-alphaVII1 Dermonecrotic toxin          *Loxosceles arizonica*
                                    \[127.979\]SY\[168.058\]VIVG\[326.398\]E\[257.168\]\[128.109\]D\[291.254\]                                                 sp C0JB31 A611 LOXHI                 phospholipase D LhSicTox-alphaVI1i Dermonecrotic toxin           *Loxosceles hirsuta*
                                    \[243.149\]R\[214.248\]D\[228.235\]I\[128.113\]\[128.353\]\[226.9\]TIY                                                     sp C0JB40 B1O LOXCS                  phospholipase D LcsSicTox-betaIC1 Dermonecrotic toxin            *Loxosceles cf. spinulosa GJB-2008*
                                    \[249.996\]S\[320.07\]C\[292.123\]PMI\[303.312\]V                                                                          sp C0JB44 B1T1 LOXSN                 phospholipase D LspiSicTox-betaIE3i Dermonecrotic toxin          *Loxosceles spinulosa*
                                    \[260.294\]C\[274.817\]N\[250.295\]N\[229.03\]\[250.931\]INNR\[248.338\]                                                   sp C0JB48 B1S LOXAS                  phospholipase D LafSicTox-betaIE2 Dermonecrotic toxin            *Loxosceles cf. spinulosa GJB-2008*
                                    \[128.075\]GP\[260.085\]\[128.08\]FNPGNYDEEE\[269.243\]                                                                    sp C0JB92 B31 LOXSN                  phospholipase D LspiSicTox-betaIII1 Dermonecrotic toxin          *Loxosceles spinulosa*
                                    HGIPCDCGRSCI                                                                                                               sp P0CE78 A1H1 LOXRE                 phospholipase D LrSicTox-alphaIA1i Dermonecrotic toxin           *Loxosceles reclusa*
                                    \[185.577\]ERR\[210.449\]WIMG\[220.232\]                                                                                   sp P0CE79 A1H2 LOXRE                 phospholipase D LrSicTox-alphaIA1ii Dermonecrotic toxin          *Loxosceles reclusa*
                                    ADNRG\[196.202\]IW                                                                                                         sp P0CE80 A1HA LOXIN                 phospholipase D LiSicTox-alphaIA1a Dermonecrotic toxin 1         *Loxosceles intermedia*
                                    E\[310.079\]DRV\[128.206\]\[127.978\]                                                                                      sp P0CE83 A1IA1 LOXIN                phospholipase D LiSicTox-alphaIA2ai Dermonecrotic toxin LiP2     *Loxosceles intermedia*
                                    RN\[172.129\]A\[185.125\]IIMAVI                                                                                            sp Q1KY79 A32 LOXLA                  phospholipase D LlSicTox-alphaIII2 Dermonecrotic toxin Ll2       *Loxosceles laeta*
                                    \[128.089\]SRD\[226.149\]DHIW                                                                                              sp Q1W694 B1Q LOXIN                  phospholipase D LiSicTox-betaID1 Dermonecrotic toxin 5           *Loxosceles intermedia*
                                    \[241.168\]D\[128.065\]\[246.052\]D\[306.802\]\[314.355\]EF                                                                sp Q1W695 A21 LOXIN                  phospholipase D LiSicTox-alphaII1 Dermonecrotic toxin 4          *Loxosceles intermedia*
                                    \[144.192\]\[184.287\]\[171.423\]\[244.328\]\[212.328\]AFTDD\[157.983\]\[314.318\]                                         sp Q27Q54 B1H2 LOXIN                 phospholipase D LiSicTox-betaIA1ii Dermonecrotic toxin-like II   *Loxosceles intermedia*
                                    \[271.172\]AI\[141.933\]\[167.905\]\[170.252\]EEI\[276.104\]\[127.878\]                                                    sp Q2XQ09 B1H1 LOXIN                 phospholipase D LiSicTox-betaIA1i Dermonecrotic toxin-like I     *Loxosceles intermedia*
                                    Y\[128.246\]E\[128.214\]IIIF                                                                                               sp Q5YD77 A1KA LOXBO                 phospholipase D LbSicTox-alphaIB1a Dermonecrotic toxin Lb1       *Loxosceles boneti*
                                    M\[169.966\]D\[227.167\]DIA\[204.21\]\[238.193\]N                                                                          sp Q8I912 B1H LOXLA                  phospholipase D LlSicTox-betaIA1 Dermonecrotic toxin LlH10       *Loxosceles laeta*
                                    \[252.158\]\[172.24\]AG\[128.07\]IIS\[346.153\]                                                                            sp Q8I913 A331 LOXLA                 phospholipase D LlSicTox-alphaIII3i Dermonecrotic toxin LlH13    *Loxosceles laeta*
                                    I\[248.195\]\[172.042\]RTNCC\[317.124\]\[316.196\]                                                                         tr G8GZ61 G8GZ61 9ARAC               Sphingomyelinase D A1                                            *Loxosceles adelaida*
                                    GMDIPNIRI\[198.131\]\[274.115\]                                                                                            TSA 2, Contig: LIS181                putative phospholipase-D                                         *Loxosceles intermedia*
                                    IADYE\[245.445\]RGF                                                                                                        TSA 3, Contig: LIC316                putative phospholipase-D                                         *Loxosceles intermedia*
                                    \[229.079\]VNDYDCA\[278.03\]\[197.89\]\[257.788\]N\[341.945\]F\[188.387\]GGI\[173.846\]E\[203.936\]\[227.312\]\[212.04\]   TSA 1, Contig: LIS124                putative phospholipase-D                                         *Loxosceles intermedia*
   ICK-peptide                      \[288.103\]\[276.948\]A\[228.135\]PETA\[217.192\]E\[258.063\]GH\[270.214\]                                                 gi 118574181 sp Q27Q53.1 TX4 LOXIN   U1-sicaritoxin-Li1c LiTx4                                        *Loxosceles intermedia*
                                    \[141.867\]GCTMGVC\[262.034\]G\[127.99\]                                                                                   gi 74786589 sp Q6B4T3.1 TX3 LOXIN    U2-sicaritoxin-Li1a LiTx3                                        *Loxosceles intermedia*
                                    \[170.014\]T\[257.226\]\[128.082\]CPAWSHER                                                                                 gi 74786590 sp Q6B4T4.1 TX2 LOXIN    U1-sicaritoxin-Li1b LiTx2                                        *Loxosceles intermedia*
                                    \[128.076\]\[198.175\]C\[128.129\]\[257.053\]AWSH\[285.151\]ECR                                                            gi 74786591 sp Q6B4T5.1 TX1 LOXIN    U1-sicaritoxin-Li1a LiTx1                                        *Loxosceles intermedia*
                                    \[242.133\]VECICSPSYYP\[154.122\]\[128.073\]                                                                               TSA 1, Contig: LIC275                putative LiTx3                                                   *Loxosceles intermedia*
                                    \[128.047\]GI\[220.146\]\[299.366\]THH\[128.119\]Y\[196.17\]E\[316.185\]                                                   TSA 1, Contig: LIC298                putative LiTx3                                                   *Loxosceles intermedia*
                                    WVI\[213.183\]FE\[230.39\]\[229.002\]DWG\[288.987\]\[127.905\]VV\[128.365\]V\[285.053\]                                    TSA 1, Contig: LIS111                putative LiTx3                                                   *Loxosceles intermedia*
                                    \[174.128\]TVPVYAECGR                                                                                                      TSA 1, Contig: LIS14                 putative LiTx3                                                   *Loxosceles intermedia*
                                    \[128.108\]\[128.122\]NVMRIYVG                                                                                             TSA 1, Contig: LIS64                 putative LiTx3                                                   *Loxosceles intermedia*
                                    AGGASE\[288.32\]V\[288.068\]E                                                                                              TSA 1, Contig: LIC255                putative LiTx4                                                   *Loxosceles intermedia*
                                                                                                                                                                                                                                                                      
  Toxin class                                                                                                                                                                                                                                                         
   ICK-peptide                      \[174.137\]GIPNASGSIGR                                                                                                     TSA 2, Contig: LIC315                putative LiTx3                                                   *Loxosceles intermedia*
                                    R\[217.187\]\[200.251\]FVPVG\[174.181\]G                                                                                   TSA 2, Contig: LIS1                  putative LiTx3                                                   *Loxosceles intermedia*
                                    GAD\[225.773\]\[283.154\]\[216.215\]                                                                                       TSA 2, Contig: LIS161                putative LiTx3                                                   *Loxosceles intermedia*
                                    \[342.104\]\[142.018\]\[174.19\]\[275.359\]TCHGPNWAA\[342.104\]                                                            TSA 2, Contig: LIS33                 putative LiTx3                                                   *Loxosceles intermedia*
                                    \[371.939\]WNYA\[199.308\]\[128.365\]STII                                                                                  TSA 3, Contig: LIC212                putative LiTx3                                                   *Loxosceles intermedia*
                                    \[128.037\]SSFEDF\[227.173\]VDCNS\[261.16\]                                                                                TSA 3, Contig: LIS21                 putative LiTx3                                                   *Loxosceles intermedia*
                                    G\[216.293\]CSDG\[342.128\]DIPC\[128.288\]                                                                                 TSA 3, Contig: LIS35                 putative LiTx3                                                   *Loxosceles intermedia*
                                    IGISSD\[320.03\]PDW\[128.125\]                                                                                             TSA 3, Contig: LIS36                 putative LiTx3                                                   *Loxosceles intermedia*
                                    ECI\[241.167\]\[241.217\]\[345.95\]                                                                                        TSA 3, Contig: LIS43                 putative LiTx3                                                   *Loxosceles intermedia*
                                    AAGDTN\[259.089\]\[229.905\]\[237.813\]\[320.42\]W\[128.09\]                                                               TSA 3, Contig: LIS44                 putative LiTx3                                                   *Loxosceles intermedia*
                                    RCE\[224.918\]GI\[128.1\]DISE                                                                                              TSA 3, Contig: LIS57                 putative LiTx3                                                   *Loxosceles intermedia*
                                    \[226.296\]PNI\[128.014\]\[185.165\]T\[247.019\]CNN\[226.997\]                                                             TSA 3, Contig: LIC381                putative neurotoxin like-magi-3                                  *Loxosceles intermedia*
                                    \[258.986\]VCYC\[208.258\]FGV\[128.123\]NC\[128.024\]                                                                      TSA 3, Contig: LIS20                 putative neurotoxin like-magi-3                                  *Loxosceles intermedia*
                                    GIRSATTPGNA\[128.185\]Y                                                                                                    sp P0CE83 A1IA1 LOXIN                phospholipase D LiSicTox-alphaIA2ai Dermonecrotic toxin LiP2     *Loxosceles intermedia*
                                    \[199.081\]YD\[225.268\]DDWCCG\[199.016\]                                                                                  sp Q27Q53 TX4 LOXIN                  U1-sicaritoxin-Li1c LiTx4                                        *Loxosceles intermedia*
                                    \[213.19\]\[128.003\]Y\[127.926\]\[299.318\]\[275.069\]R\[244.958\]\[183.934\]\[277.077\]\[128.226\]G\[141.885\]           sp Q6B4T3 TX3 LOXIN                  U2-sicaritoxin-Li1a LiTx3                                        *Loxosceles intermedia*
                                    CT\[224.823\]CGPYY                                                                                                         sp Q6B4T4 TX2 LOXIN                  U1-sicaritoxin-Li1b LiTx2                                        *Loxosceles intermedia*
                                    \[320.096\]\[128.127\]\[128.065\]GTPC\[128.107\]CPAWSHER\[289.113\]\[174.07\]                                              sp Q6B4T5 TX1 LOXIN                  U1-sicaritoxin-Li1a LiTx1                                        *Loxosceles intermedia*
                                    TG\[128.074\]\[128.206\]FI                                                                                                 TSA 1, Contig: LIS15                 putative LiTx1                                                   *Loxosceles intermedia*
                                    \[260.124\]\[257.99\]\[260.764\]DAIESEDPV\[208.163\]                                                                       TSA 1, Contig: LIS159                putative LiTx1                                                   *Loxosceles intermedia*
                                    SV\[127.961\]\[200.118\]GI\[315.972\]\[128.206\]E\[142.111\]                                                               TSA 1, Contig: LIS163                putative LiTx3                                                   *Loxosceles intermedia*
                                    M\[247.954\]\[271.519\]E\[198.253\]\[128.081\]D\[200.22\]                                                                  TSA 2, Contig: LIS31                 putative LiTx3                                                   *Loxosceles intermedia*
                                    GAG\[143.963\]NIFA\[127.947\]                                                                                              TSA 2, Contig: LIS76                 putative LiTx3                                                   *Loxosceles intermedia*
                                    \[127.704\]T\[128.06\]FCV\[128.02\]NG\[128.165\]PICP\[128.162\]\[167.895\]G                                                TSA 3, Contig: LIC337                putative LiTx1                                                   *Loxosceles intermedia*
                                    G\[266.174\]CHAFGSNCR                                                                                                      TSA 2, Contig: LIS229                putative neurotoxin like-magi-3                                  *Loxosceles intermedia*
   Serine protease inhibitor        \[128.02\]CP\[235.787\]\[198.175\]\[143.863\]G\[241.815\]DV\[127.896\]\[218.419\]G                                         TSA 1, Contig: LIS209                putative serine protease inhibitor                               *Loxosceles intermedia*
   Serine protease                  \[269.335\]\[262.236\]S\[244.714\]WASFP\[211.817\]SA\[128.235\]I\[269.335\]                                                TSA 1, Contig: LIC305                putative serine protease                                         *Loxosceles intermedia*
   Venom allergen                   \[346.178\]\[257.117\]N\[215.219\]\[298.78\]\[217.218\]ND\[260.144\]IG\[256.421\]\[372.04\]                                TSA 2, Contig: LIC179                putative venom allergen                                          *Loxosceles intermedia*
   Hyaluronidase                    V\[207.937\]SSEY\[211.831\]I\[326.363\]\[319.484\]                                                                         TSA 1, Contig: LIS222                putative hyaluronidase                                           *Loxosceles intermedia*
   TCTP                             \[256.849\]\[275.401\]\[210.175\]I\[252.242\]TA\[244.108\]\[200.309\]\[241.062\]N\[170.078\]IIED\[372.344\]                tr G3LU44 G3LU44 LOXIN               translationally-controlled tumor protein homolog LiTCTP          *Loxosceles intermedia*
                                    \[269.086\]FGIMAP\[225.403\]GEIR                                                                                           gi 344995179 gb AEN55462.1           translationally controlled tumor protein LiTCTP                  *Loxosceles intermedia*
  **Cellular processes proteins**   \[200.059\]VHEDNI\[128.065\]E\[128.062\]H\[128.193\]\[262.127\]                                                            TSA 1, Contig: LIC216                putative 60S ribosomal protein L10                               *Loxosceles intermedia*
                                    \[199.078\]CT\[297.052\]F\[264.084\]\[233.709\]GCPSR                                                                       TSA 1, Contig: LIS275                putative cysteine-rich PDZ-binding protein                       *Loxosceles intermedia*
                                    \[269.045\]D\[173.858\]DPDCDC\[211.944\]D\[173.937\]D\[269.044\]                                                           TSA 1 Contig: LIS239                 putative cytochrome P450 mRNA                                    *Loxosceles intermedia*
                                    I\[204.06\]CV\[128.097\]\[297.04\]                                                                                         TSA 1, Contig: LIS199                putative histone H2B                                             *Loxosceles intermedia*
                                    \[241.241\]\[210.11\]DFYEI\[170.035\]SA\[262.036\]                                                                         TSA 1, Contig: LIS189                putative myosin heavy chain                                      *Loxosceles intermedia*
                                    \[128.159\]GF\[218.024\]D\[127.978\]VVIA                                                                                   TSA 1, Contig: LIC349                putative secreted salivary gland peptide                         *Loxosceles intermedia*
                                    \[262.073\]I\[243.142\]PSNPSCR                                                                                             TSA 2, Contig: LIC232                putative 60S ribosomal protein L27                               *Loxosceles intermedia*
                                    \[216.109\]IVISNPDINH\[260.307\]\[226.167\]\[128.074\]                                                                     TSA 2, Contig: LIC283                putative actin related protein 3                                 *Loxosceles intermedia*
                                    TED\[128.098\]V\[229.139\]                                                                                                 TSA 2, Contig: LIS258                putative glycoprotein hormone alpha-2 precurso                   *Loxosceles intermedia*
                                    \[128.037\]SSFEDF\[227.173\]VDCNS\[261.16\]                                                                                TSA 2, Contig: LIS217                putative myosin light chain                                      *Loxosceles intermedia*
                                    \[199.18\]SIDIIAS\[128.129\]DVMDR                                                                                          TSA 2, Contig: LIS39                 putative Na/Pi co-transporter                                    *Loxosceles intermedia*
                                    \[269.086\]FGIMAP\[225.403\]GEIR                                                                                           TSA 2, Contig: LIS280                putative ribosomal protein L18a                                  *Loxosceles intermedia*
                                    \[247.11\]G\[128.088\]I\[183.991\]N\[210.738\]\[262.174\]\[285.2\]                                                         TSA 2, Contig: LIS213                putative ribosomal protein S3                                    *Loxosceles intermedia*
                                    Y\[127.918\]GV\[143.679\]I\[196.241\]AGR                                                                                   TSA 3, Contig: LIC307                putative angiotensin-converting enzyme                           *Loxosceles intermedia*
                                    VGSIPIDI\[128.058\]                                                                                                        TSA 3, Contig: LIC368                putative myosin light chain                                      *Loxosceles intermedia*
                                    \[128.071\]SAI\[250.284\]IS\[127.926\]N                                                                                    TSA 3, Contig: LIC207                putative troponin C                                              *Loxosceles intermedia*
                                    GTIPVT\[323.12\]P\[128.197\]                                                                                               TSA 3, Contig: LIS253                putative troponin T                                              *Loxosceles intermedia*
                                    \[128.057\]CW\[283.922\]E\[127.782\]\[128.342\]GA                                                                          TSA 3, Contig: LIS216                putative zinc finger protein                                     *Loxosceles intermedia*
                                    \[128.066\]CG\[169.924\]S\[293.695\]D\[211.062\]C\[143.962\]                                                               TSA 1, Contig: LIS257                putative cAMP-responsive element-binding protein-like 2-like     *Loxosceles intermedia*
                                    HVSV\[128.009\]                                                                                                            TSA 1, Contig: LIC219                putative glutamine synthetase                                    *Loxosceles intermedia*
                                    \[262.165\]P\[230.085\]D\[128.062\]                                                                                        TSA 2, Contig: LIS220                putative 60S ribosomal protein L6                                *Loxosceles intermedia*
                                    \[268.215\]HCTCDDVC\[128.023\]R\[275.259\]Y                                                                                TSA 2, Contig: LIS231                putative calmodulin                                              *Loxosceles intermedia*
                                    \[274.04\]TPIRIN\[210.228\]II\[228.096\]                                                                                   TSA 2, Contig: LIS27                 putative Na/Pi co-transporter                                    *Loxosceles intermedia*
                                    \[372.255\]DEIIN\[171.15\]IE\[200.054\]E\[201.127\]S\[226.48\]HG\[293.174\]\[372.288\]                                     TSA 2, Contig: LIS265                putative selenoprotein M                                         *Loxosceles intermedia*
                                    NW\[211.918\]RIR\[298.994\]\[248.176\]                                                                                     TSA 2, Contig: LIS205                putative ubiquitin                                               *Loxosceles intermedia*
                                    \[253.085\]IG\[200.301\]T\[251.496\]\[171.357\]ED                                                                          tr Q6W974 Q6W974 LOXRE               codium/potassium ATPase alpha subunit                            *Loxosceles reclusa*
                                    YHNN\[232.454\]ISII                                                                                                        tr B8R316 B8R316 9ARAC               NADH-ubiquinone oxidoreductase chain 1                           *Loxosceles baja*
                                    \[276.09\]MISMEVG\[307.07\]\[259.494\]Y                                                                                    tr B8R320 B8R320 LOXDE               NADH-ubiquinone oxidoreductase chain 2                           *Loxosceles deserta*
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                                    \[128.205\]MFTIIM\[235.906\]GV\[215.128\]                                                                                  tr B8R326 B8R326 9ARAC               NADH-ubiquinone oxidoreductase chain 1                           *Loxosceles chinateca*
                                    \[245.288\]RA\[260.078\]NTSTIGTA\[212.046\]R                                                                               tr B8R332 B8R332 9ARAC               NADH-ubiquinone oxidoreductase chain 1                           *Loxosceles kaiba*
                                    S\[246.297\]\[301.019\]IVS\[170.255\]H                                                                                     tr B8R341 B8R341 9ARAC               NADH-ubiquinone oxidoreductase chain 1                           *Sicarius aff. patagonicus*
                                    RT\[255.953\]\[231.083\]\[299.111\]CVG                                                                                     tr C1ITN3 C1ITN3 LOXAS               cytochrome c oxidase subunit 1                                   *Loxosceles aff. spinulosa*
                                    I\[211.14\]\[268.32\]I\[187.685\]IV\[246.077\]                                                                             tr C1ITP7 C1ITP7 9ARAC               cytochrome c oxidase subunit 1                                   *Sicarius dolichocephalus*
                                    FF\[238.18\]IITAG\[273.235\]                                                                                               tr C1ITR2 C1ITR2 9ARAC               cytochrome c oxidase subunit 1                                   *Drymusa serrana*
                                    YEDRIVVR\[230.004\]                                                                                                        tr C1ITR3 C1ITR3 9ARAC               cytochrome c oxidase subunit 1                                   *Drymusa dinora*
                                    \[316.142\]TVYCMSIEITA\[226.21\]IEDI\[241.221\]                                                                            tr C1IZB2 C1IZB2 LOXLA               cytochrome c oxidase subunit 1                                   *Loxosceles laeta*
                                    GVI\[248.157\]NITGYR                                                                                                       tr C5J3X9 C5J3X9 LOXRU               cytochrome c oxidase subunit 1                                   *Loxosceles rufescens*
                                    IA\[128.08\]MFTIIE\[216.039\]GV\[215.166\]                                                                                 tr B8R317 B8R317 LOXAP               NADH-ubiquinone oxidoreductase chain 1                           *Loxosceles apachea*
                                    \[278.338\]A\[234.386\]WHVEN\[210.973\]VNI\[210.062\]                                                                      tr B8R335 B8R335 LOXS4               NADH-ubiquinone oxidoreductase chain 1                           *Loxosceles sp.*
                                    \[265.105\]V\[213.051\]\[172.098\]A\[283.126\]Y\[201.071\]\[210.087\]\[278.104\]\[269.011\]RGIVMV\[283.117\]               tr C1ITR3 C1ITR3 9ARAC               cytochrome c oxidase subunit 1                                   *Drymusa dinora*
                                    \[127.983\]AG\[153.948\]ACTGEMGSCG                                                                                         tr C5J3X7 C5J3X7 LOXGA               cytochrome c oxidase subunit 1                                   *Loxosceles gaucho*
                                    YSVFCMM\[128.12\]V                                                                                                         tr C5J3X9 C5J3X9 LOXRU               cytochrome c oxidase subunit 1                                   *Loxosceles rufescens*
                                    \[225.309\]SWD\[217.039\]\[271.219\]C\[258.226\]\[218.143\]\[302.82\]GMIGSEN                                               tr Q6W974 Q6W974 LOXRE               sodium/potassium ATPase alpha subunit                            *Loxosceles reclusa*

[^1]: P.C.C., S.S.V., A.S.-R., J.S.G.F., and D.T.-S. conceived and designed the work. D.T.-S. and A.V.B. collected venom samples. D.T.-S. and A.V.B. performed sample preparation. P.C.C. designed the protocol for data acquisition by mass spectrometry and F.K.M. ran the samples; together with V.C.B., they discussed alternatives for generating and analyzing the data. N.B. and A.G. developed and applied the method for data analysis. P.C.C., D.T.-S., F.V.L., V.C.B., and A.S.-R. analyzed the results and wrote the manuscript. All authors reviewed the manuscript.
